ATE279214T1 - Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben - Google Patents

Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben

Info

Publication number
ATE279214T1
ATE279214T1 AT99906771T AT99906771T ATE279214T1 AT E279214 T1 ATE279214 T1 AT E279214T1 AT 99906771 T AT99906771 T AT 99906771T AT 99906771 T AT99906771 T AT 99906771T AT E279214 T1 ATE279214 T1 AT E279214T1
Authority
AT
Austria
Prior art keywords
thrombes
bibapcitide
imaging
treatment
pharmaceutical compositions
Prior art date
Application number
AT99906771T
Other languages
English (en)
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Application granted granted Critical
Publication of ATE279214T1 publication Critical patent/ATE279214T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99906771T 1998-02-06 1999-02-05 Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben ATE279214T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (1)

Publication Number Publication Date
ATE279214T1 true ATE279214T1 (de) 2004-10-15

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906771T ATE279214T1 (de) 1998-02-06 1999-02-05 Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben

Country Status (25)

Country Link
US (1) US6028056A (de)
EP (1) EP1053027B1 (de)
JP (1) JP2003532617A (de)
KR (1) KR100452390B1 (de)
CN (1) CN1103606C (de)
AR (1) AR018546A1 (de)
AT (1) ATE279214T1 (de)
AU (1) AU761778B2 (de)
BR (1) BR9908352A (de)
CA (1) CA2319544C (de)
DE (1) DE69921096T2 (de)
DK (1) DK1053027T3 (de)
EA (1) EA005406B1 (de)
ES (1) ES2229681T3 (de)
HU (1) HUP0100887A3 (de)
IL (1) IL137076A (de)
NO (1) NO20003881L (de)
NZ (1) NZ505085A (de)
PE (1) PE20000250A1 (de)
PL (1) PL342253A1 (de)
PT (1) PT1053027E (de)
SI (1) SI1053027T1 (de)
SK (1) SK284463B6 (de)
TW (1) TWI246425B (de)
WO (1) WO1999039747A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6243335B2 (ja) 2011-08-17 2017-12-06 ピラマル イメージング ソシエテ アノニム 血小板固有の糖タンパク質ＩＩｂ／ＩＩＩａに結合する化合物と血栓造影のためのその使用
CA2900595A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
CN117177775A (zh) * 2021-04-14 2023-12-05 启德医药科技（苏州）有限公司 连接子、缀合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
EP0641222B1 (de) * 1992-05-21 2000-09-06 Diatide, Inc. Technetium-99m markierte peptide zur bilderzeugung von thrombus

Also Published As

Publication number Publication date
PT1053027E (pt) 2005-01-31
JP2003532617A (ja) 2003-11-05
CN1290179A (zh) 2001-04-04
NO20003881D0 (no) 2000-07-28
AU2660499A (en) 1999-08-23
TWI246425B (en) 2006-01-01
HK1032198A1 (en) 2001-07-13
PE20000250A1 (es) 2000-06-02
CA2319544C (en) 2006-07-04
CA2319544A1 (en) 1999-08-12
US6028056A (en) 2000-02-22
SK11392000A3 (sk) 2001-03-12
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
EA005406B1 (ru) 2005-02-24
KR20010040676A (ko) 2001-05-15
EP1053027B1 (de) 2004-10-13
IL137076A0 (en) 2001-06-14
DE69921096D1 (de) 2004-11-18
DE69921096T2 (de) 2006-02-02
IL137076A (en) 2004-08-31
EA200000820A1 (ru) 2001-02-26
HUP0100887A3 (en) 2003-08-28
SI1053027T1 (en) 2005-04-30
DK1053027T3 (da) 2005-01-17
BR9908352A (pt) 2000-11-28
AU761778B2 (en) 2003-06-12
NZ505085A (en) 2002-10-25
ES2229681T3 (es) 2005-04-16
EP1053027A1 (de) 2000-11-22
SK284463B6 (sk) 2005-04-01
PL342253A1 (en) 2001-06-04
CN1103606C (zh) 2003-03-26
HUP0100887A2 (hu) 2001-06-28
AR018546A1 (es) 2001-11-28
NO20003881L (no) 2000-07-28

Similar Documents

Publication Publication Date Title
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
DE69822410D1 (de) Modularkatheter zur Abbildung und Behandlung und Montageverfahren
DE69839647D1 (de) Vorbeugung und behandlung von amyloidogener krankheit
DE60042451D1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
ATE300597T1 (de) Behandlung von geweben
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ATE349216T1 (de) Behandlung von darmverstopfung
DE69942680D1 (de) Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE69837968D1 (de) Diagnose und behandlung myocardieller fehler
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
ATE279214T1 (de) Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben
DE69924379D1 (de) Verbindungen und zubereitungen zur behandlung der ischämie des gewebes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1053027

Country of ref document: EP

REN Ceased due to non-payment of the annual fee